Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis

Journal of Nuclear Cardiology

Volumn 20, Issue 6, 2013, Pages 1108-1115

  Gormsen, Lars C ^a   Christensen, Nana Louise ^a   Bendstrup, Elisabeth ^a   Tolbod, Lars Poulsen ^a   Nielsen, Søren Steen ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

Author keywords

Cardiac sarcoidosis; fluorodeoxyglucose; heart failure; inflammation

Indexed keywords

FATTY ACID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; HEPARIN; INSULIN; SODIUM CHLORIDE; SOMATOSTATIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; FATTY ACID BLOOD LEVEL; FEMALE; HEART LEFT VENTRICLE; HUMAN; IMAGING SOFTWARE; INSULIN RELEASE; INTERMETHOD COMPARISON; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SARCOIDOSIS;

ADULT; AGED; CARDIOMYOPATHIES; CROSS-OVER STUDIES; FATTY ACIDS, NONESTERIFIED; FEMALE; FLUORODEOXYGLUCOSE F18; HEPARIN; HUMANS; INSULIN; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SARCOIDOSIS; SOMATOSTATIN;

EID: 84890942322     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-013-9798-8     Document Type: Article

References (28)

1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224-34.
2. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009;120:1969-77.
3. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-11.
4. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993;103:253-8.
5. Chiu CZ, Nakatani S, Zhang G, Tachibana T, Ohmori F, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005;95:143-6.
6. Ishikawa T, Kondoh H, Nakagawa S, Koiwaya Y, Tanaka K. Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. Chest 1984;85:445-7.
7. Ratner SJ, Fenoglio JJ Jr, Ursell PC. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 1986;90:528-33.
8. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005;45:1683-90.
9. Yamagishi H, Shirai N, Takagi M, Yoshiyama M, Akioka K, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med 2003;44:1030-6.
10. van der Vusse GJ, Glatz JF, Stam HC, Reneman RS. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 1992;72:881-940.
11. Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. J Nucl Med 2007;48:1662-9.
12. Langah R, Spicer K, Gebregziabher M, Gordon L. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol 2009;16:801-10.
13. Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol 2008;190:W151-6.
14. Harisankar CN, Mittal BR, Agrawal KL, Abrar ML, Bhattacharya A. Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake. J Nucl Cardiol 2011;18:926-36.
15. Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26:1538-43.
16. Israel O, Weiler-Sagie M, Rispler S, Bar-Shalom R, Frenkel A, et al. PET/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake. J Nucl Med 2007;48:234-9.
17. Nesterov SV, Han C, Maki M, Kajander S, Naum AG, et al. Myocardial perfusion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas). Eur J Nucl Med Mol Imaging 2009;36:1594-602.
18. Youssef G, Leung E, Mylonas I, Nery P, Williams K, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012;53:241-8.
19. Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging 2010;3:1219-28.
20. Cheng VY, Slomka PJ, Ahlen M, Thomson LE, Waxman AD, et al. Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: a randomized controlled trial. J Nucl Cardiol 2010;17:286-91.
21. Heusch P, Buchbender C, Beiderwellen K, Nensa F, Hartung-Knemeyer V, et al. Standardized uptake values for [(1)(8)F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI. Eur J Radiol 2013;82:870-6.
22. Soejima K, Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 2009;20:578-83.
23. Nishiyama Y, Yamamoto Y, Fukunaga K, Takinami H, Iwado Y, et al. Comparative evaluation of 18F-FDG PET and 67 Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006;47:1571-6.
24. Ito K, Morooka M, Okazaki O, Minaminoto R, Kubota K, et al. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity. Clin Nucl Med 2013;38:128-30.
25. Soussan M, Brillet PY, Nunes H, Pop G, Ouvrier MJ, et al. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nucl Cardiol 2013;20:120-7.
26. Neglia D, De Caterina A, Marraccini P, Natali A, Ciardetti M, et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2007;293:H3270-8.
27. Heather LC, Howell NJ, Emmanuel Y, Cole MA, Frenneaux MP, et al. Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis. PLoS One 2011;6:e26326.
28. Ohira H, Tsujino I, Yoshinaga K. (1)(8)F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 2011;38:1773-83.